(Press-News.org) More than a decade ago, researchers from Brigham and Women's Hospital (BWH) demonstrated that a high dose statin, which lowered cholesterol further than a regular dose statin, provided better clinical outcomes. But questions remained about whether further reducing cholesterol would be even more effective in reducing cardiovascular-related events.
Now, results of the highly anticipated IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT), co-led by researchers at BWH and Duke Medicine, indicate that adding a second drug, ezetimibe, that blocks cholesterol absorption, resulted in a significant 6.4 percent reduction in the number of cardiovascular events.
The findings, presented as a late breaking clinical trial at the American Heart Association Scientific Sessions on Nov. 17, 2014, clarify a long-standing question in cardiac care about whether reducing cholesterol to even lower levels might improve outcomes. Complete publication of the data is expected in the coming months.
"There is a lot of evidence that demonstrates that low cholesterol is better, and our findings suggest that even lower is even better," said Christopher Cannon, MD, principal investigator of IMPROVE-IT and a cardiologist and researcher in the TIMI Study Group at BWH. "More broadly, the results of IMPROVE- IT re-emphasize the central role of lowering LDL cholesterol for the treatment of high risk patients."
In this multicenter, double-blind, placebo-controlled international randomized trial, researchers enrolled 18,144 patients with acute coronary syndrome (ACS), described as heart attacks or worsening chest pain, and all were treated according to the previously existing guidelines with a statin (simvastatin).
In the control group, patients who received statin therapy alone reached a median LDL cholesterol level of 69 mg/dl for a median of six years. Researchers found that when patients received the non-statin medication ezetimibe, in addition to the statin (ezetimibe/simvastatin combination/brand name VYTORIN), LDL cholesterol was reduced 20 percent further to a median level of 54 mg/dl, and this led to a statistically significant 6.4 percent reduction in the number of cardiovascular events. (p=0.016) After seven years, the combined rate of cardiac death, heart attack, stroke, hospitalization for worsening chest pain, or need for revascularization, was reduced from 34.7 percent in the control group to 32.7 percent in the group that received the combination therapy. Additionally, researchers report that approximately two cardiovascular events were prevented in the trial for every 100 patients treated, with the difference driven by reductions in heart attack or stroke.
"This trial demonstrates the importance of careful measurement of long-term outcomes in randomized trials for medicines that are taken for chronic diseases," said Robert Califf, MD, vice chancellor for clinical research at Duke and co-study chair of the trial. "We were looking for a small effect and we found an effect very close to what we expected, clearly favoring the group taking ezetimibe/simvastatin. The trial confirmed the existing safety profile of ezetimibe."
"Our findings suggest that, among this population of ACS patients, we may want to consider changes to our clinical guidelines, which might include an LDL cholesterol target of closer to 55, or lower," said Eugene Braunwald, MD, co-study chair, and founding chairman of the TIMI Study Group at BWH.
Additional data from the trial will be presented at the AHA meeting on Tuesday in a trial update session. The presentation, the first additional analysis of the study database led by the Duke Clinical Research Institute, will focus on the population of individuals who completed the study on medication.
"We are using this analysis as a first look at the findings of the primary analysis, and to look at the data among patients only during the time that they actually remained on treatment during the study," said Michael Blazing, MD, associate professor of medicine and director of outpatient services at the Duke Heart Center who will present the findings of the on-treatment group in the Tuesday session.
Ezetimibe is a drug approved to lower plasma cholesterol levels by decreasing absorption of LDL cholesterol in the small intestine, and is additive to the role that statins play in lowering cholesterol. Ezetimibe and the ezetimibe/simvastatin are sold by Merck, which sponsored and provided funding for this study.
INFORMATION:
WCS, NASA, And other conservation and remote sensing agencies, universities and NGOs focus on top 10 conservation questions for satellite technology
Remote sensing has and can continue to play a critical role in conserving Earth's biological diversity
Protected area management is a key use of remote sensing data
Newly formed Conservation Remote Sensing Network to apply remote sensing data to conservation challenges
NEW YORK (November 17, 2014)--Scientists from the WCS (Wildlife Conservation Society), NASA, and other organizations have partnered to focus global attention ...
Harvard Stem Cell Institute (HSCI) researchers, representing five Harvard departments and affiliated institutions as well as the Massachusetts Institute of Technology (MIT), have demonstrated that adult cells, reprogrammed into another cell type in a living animal, can remain functional over a long period.
The work by Joe Zhou, an associate professor in Harvard's Department of Stem Cell and Regenerative Biology, and his collaborators is an important advance in the effort to develop cell-based therapies for tissue repair, and specifically in the effort to develop improved ...
HOUSTON - (Nov. 17, 2014) - Offering small financial incentives doubles smoking cessation rates among socioeconomically disadvantaged smokers, according to research from The University of Texas Health Science Center at Houston (UTHealth). The findings were published last week in the American Journal of Public Health.
Tobacco use is the leading cause of preventable death in the United States, according to the Centers for Disease Control and Prevention. Thanks to public health efforts, smoking rates have declined to 18 percent among American adults. However, nearly 30 percent ...
If your surname reveals that you descended from the "in" crowd in the England of 1066--the Norman Conquerors--then even now you are more likely than the average Brit to be upper class. To a surprising degree, the social status of your ancestors many generations in the past still exerts an influence on your life chances, say Gregory Clark of the University of California, Davis, in the US and Neil Cummins of the London School of Economics in the UK. They used the Oxbridge attendance of people with rare English surnames (last names) to track social mobility from 1170 to 2012. ...
(NEW YORK - November 17) Brief usage of the painkiller oxycodone may impair behavioral flexibility even after that use ends, suggesting impaired decision-making as an enduring consequence of exposure, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published November 17 in the journal Learning and Memory.
The Mount Sinai study investigated behavioral flexibility, the ability to select new responses when otherwise familiar circumstances change. In people and rodents exposed to drugs of addiction, repeated actions can become automated ...
Raptors, or birds of prey, some of which are endangered species, typically live in environments that provide natural land cover, such as forests and grasslands. Protecting endangered raptor species helps maintain food chain balance and prevents overpopulation of common raptor prey, such as snakes and rodents. As more businesses are built on the edges of urban areas, land where raptors once lived becomes industrialized, which raises concerns about the consequences of habitat destruction on raptor populations. Now, University of Missouri researchers have found that businesses ...
ANN ARBOR -- Researchers at the University of Michigan have discovered how a previously unknown hormone serves as a messenger from fat cells to the liver and are investigating the potential of developing a new treatment for metabolic disorders.
Jiandie Lin of the Life Sciences Institute described how in mice the hormone, NRG4, is secreted by so-called brown fat cells and communicates with the liver to regulate the conversion of sugar into fat. Mice without NRG4 became obese and developed hallmarks of type 2 diabetes and fatty liver disease. When scientists genetically ...
The first tropical cyclone of the Southern Indian Ocean cyclone season has formed over 300 miles from Diego Garcia. When NASA-NOAA Suomi NPP satellite passed over Tropical Storm Adjali the VIIRS instrument aboard took a visible picture of the storm that showed bands of thunderstorms wrapped around its center.
NASA-NOAA's Suomi NPP satellite passed over Tropical Storm Adjali on Nov. 17 at 09:56 UTC (4:56 a.m. EDT) and the Visible Infrared Imaging Radiometer Suite (VIIRS) instrument aboard captured a visible picture of the storm. The VIIRS image showed that the storm ...
RIVERSIDE, Calif. (http://www.ucr.edu) -- Ideas from mid-level managers that can benefit an organization are less likely to be passed up to superiors as hierarchy in the organization increases, according to a just published paper by an assistant professor at the University of California, Riverside.
"I like to call this hermit crab syndrome," said Boris Maciejovsky, an assistant professor of management at UC Riverside's School of Business Administration. "When mid-level managers feel their ideas are not reflected in top management decisions they withdraw, like a hermit ...
In a breakthrough that could substantially improve physicians' ability to rapidly evaluate patients with suspected Ebola, radiologists at Emory University Hospital have devised a protocol for obtaining chest radiographs using portable computed radiography. The protocol not only limits the exposure of personnel and equipment to body fluids, it also minimizes the risk of contaminants leaving the isolation unit by use of thorough decontamination procedures.
The step-by-step protocol is outlined in an article published ahead of print in the American Journal of Roentgenology ...
